Cidara Therapeutics expands partnership with WuXi XDC
CD421 is Cidara’s lead oncology candidate. Credit: National Cancer Institute on Unsplash. Cidara Therapeutics has announced the expansion of its ...
Read moreCD421 is Cidara’s lead oncology candidate. Credit: National Cancer Institute on Unsplash. Cidara Therapeutics has announced the expansion of its ...
Read moreCidara Therapeutics, Inc.Agreement builds upon the existing relationship with WuXi XDC for CMC development and GMP manufacturing of Cidara’s CD388 ...
Read moreSAN DIEGO and SHANGHAI, China, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing ...
Read moreU.S. stocks traded mixed, with the Nasdaq Composite dropping around 90 points on Monday. Here are some big stocks recording ...
Read moreNEW YORK, June 8, 2022 /PRNewswire/ -- OnCusp Therapeutics announced today a licensing agreement with Multitude Therapeutics for the development and ...
Read moreWhen it comes to high-flying cryptocurrencies, Shiba Inu ( SHIB 8.14% ) is among the most visible. Fueled by a ...
Read moreWith an FDA approval in hand, ADC Therapeutics has enlisted its old friend Avid Bioservices to rev up commercial manufacturing for ...
Read moreWe publish a comprehensive news feed covering all news relevant to the crypto user, covering main industry news, politics and regulation as well as consumer-level “news you can use” (practical stuff), including handy DIY tips, links to useful tools, unbiased reviews and opinions revolving around cryptocurrency. Simple logic and real-world examples are preferred before technical jargon and personal rants.